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Aldo-keto reductases 1B1, 1B10 and 1C1 (AKR1B1, AKR1B10, AKR1C1) are 
NADPH-dependent enzymes metabolizing a broad spectrum of carbonyl-bearing 
substrates. These enzymes from the superfamily of aldo-keto reductases mediate  
the reduction of endogenous compounds such as hormones and sugars as well as various 
xenobiotics and drugs. Beside their physiological roles, they significantly participate  
in the genesis of severe diseases (e.g. cancer, diabetes etc.). Inhibition of AKR1B1, 
AKR1B10 and AKR1C1 is accepted as promising therapeutic approach for the treatment 
of these diseases. The goal of the present work was to prepare mammalian vectors 
encoding AKR1B1, AKR1B10 and AKR1C1. 
Primer design and cDNA amplification were the first steps. Primers contained  
the sequence recognized by restriction endonucleases present in the multicloning site  
of the pCI plasmid which allowed for the generation of cohesive ends and the consequent 
joining of insert with plasmid by ligation. Prepared vectors were transformed into 
Escherichia coli HB101 bacteria. Fruitfulness of insert cloning was verified  
by electrophoresis and control and back restriction in plasmids isolated from chosen 
colonies. Plasmids with a potential for successful encloning of insert were amplified, 
isolated and purified in midi format and verified by sequencing analysis.  
Mammalian pCI vectors encoding AKR1B1, AKR1B10 and AKR1C1 were 
successfully prepared. These vectors will be utilized in the future for transfections  
in studies focused on the characterization of inhibitory and substrate affinity  
of selected enzymes. 
